切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2022, Vol. 11 ›› Issue (02) : 176 -181. doi: 10.3877/cma.j.issn.2095-3232.2022.02.013

临床研究

结直肠癌大胆管转移病理特征及其与术后复发的关系
王娟娟1, 张锐2, 吴文睿2, 刘超2, 曾弘1,()   
  1. 1. 510120 广州,中山大学孙逸仙纪念医院广东省恶性肿瘤表观遗传学与基因调控重点实验室;510120 广州,中山大学孙逸仙纪念医院病理科
    2. 510120 广州,中山大学孙逸仙纪念医院广东省恶性肿瘤表观遗传学与基因调控重点实验室;510120 广州,中山大学孙逸仙纪念医院胆胰外科
  • 收稿日期:2021-12-17 出版日期:2022-04-10
  • 通信作者: 曾弘
  • 基金资助:
    广东省自然科学基金面上项目(2016A030313840)

Pathological features of colorectal cancer with large bile duct metastasis and its relation with postoperative recurrence

Juanjuan Wang1, Rui Zhang2, Wenrui Wu2, Chao Liu2, Hong Zeng1,()   

  1. 1. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China; Department of Pathology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China
    2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China; Department of Biliary and Pancreatic Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China
  • Received:2021-12-17 Published:2022-04-10
  • Corresponding author: Hong Zeng
引用本文:

王娟娟, 张锐, 吴文睿, 刘超, 曾弘. 结直肠癌大胆管转移病理特征及其与术后复发的关系[J]. 中华肝脏外科手术学电子杂志, 2022, 11(02): 176-181.

Juanjuan Wang, Rui Zhang, Wenrui Wu, Chao Liu, Hong Zeng. Pathological features of colorectal cancer with large bile duct metastasis and its relation with postoperative recurrence[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(02): 176-181.

目的

探讨结直肠癌大胆管转移的病理特征及其与术后复发的关系。

方法

回顾性分析2016年1月至2020年10月在中山大学孙逸仙纪念医院诊治的5例影像学检查发现大胆管内占位且经术后病理证实结直肠癌大胆管内转移患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男4例,女1例;年龄48~59岁,中位年龄54岁。5例原发病灶均为左半结直肠,均同时合并肝实质转移灶,其中多发结节4例,单发结节1例。采用HE染色和免疫组化方法检测CK7、CK20和CDX2蛋白的表达。观察患者的病理特征、诊治及预后情况。

结果

同期555例结直肠癌肝转移患者,大胆管转移发生率0.9%(5/555)。根据患者转移灶部位采用肝切除或病灶切除。病理学检查发现肝转移灶分化程度与原发灶相同,其中中度分化4例,低分化1例;扩张的大胆管内肿物填充,胆管转移灶组织形态与肝实质转移癌相同。胆管转移灶生长方式包括管腔内息肉状生长、癌细胞沿着胆管基底膜生长、肝外胆管孤立转移3种。免疫组化染色显示转移灶癌细胞CK20、CDX2均阳性,CK7阴性;残留胆管上皮CK7阳性,CK20、CDX2均阴性。术后3例复发,复发时间为术后8~32个月。

结论

结直肠癌大胆管转移具有独特的病理形态和生物学行为,可沿胆管树连续性或非连续性播散。明确诊断,解剖性肝胆管切除,彻底清除受累肝胆管,以及术后密切监测,是改善预后的有效手段。

Objective

To investigate the pathological features and effect of colorectal cancer with large bile duct metastases on postoperative recurrence.

Methods

Clinical data of 5 patients who were detected with space-occupying masses in the large bile ducts by imaging examination and pathologically diagnosed with colorectal cancer and large bile duct metastases admitted to Sun Yat-sen Memorial Hospital of Sun Yat-sen University from January 2016 to October 2020 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 4 patients were male and 1 female, aged from 48 to 59 years, with a median age of 54 years. Primary lesions were located in the left colorectum in 5 patients, complicated with liver parenchymal metastases, including 4 cases of multiple nodules and 1 case of single nodule. The expression levels of CK7, CK20 and CDX2 proteins were measured by HE staining and immunohistochemistry. Pathological features, diagnosis and treatments, and clinical prognosis of the patients were observed.

Results

Among 555 patients with liver metastases from colorectal cancer, the incidence rate of large duct metastasis was 0.9%(5/555). Liver resection or lesion resection was performed according to the location of metastatic lesions. Pathological examination showed that the degree of differentiation of liver metastases was the same to that of primary lesions, including 4 cases of moderately-differentiation and 1 case of lowly-differentiation. The dilated large bile duct was filled with masses, and the histological morphology of bile duct metastases was the same as that of liver parenchymal metastases. The growth patterns of bile duct metastases consisted of intraductal polypoid growth, cancer cell growth along with the bile duct basement membrane and isolated extrahepatic bile duct metastasis. Immunohistochemical staining demonstrated that CK20 and CDX2 in the metastatic cancer cells were positive, whereas CK7 negative. The residual bile duct epithelium was positive for CK7, whereas negative for CK20 and CDX2. 3 cases recurred between postoperative 8 and 32 months.

Conclusions

Large bile duct metastasis from colorectal cancer is manifested with typical pathological morphology and biological behavior, which can spread along with the biliary tree in a continuous or discontinuous pattern. Definite diagnosis, anatomical resection of hepatobiliary ducts, complete removal of the involved bile ducts, and intimate postoperative monitoring are effective approaches to improve the patients' prognosis.

表1 五例结直肠癌大胆管转移患者基本情况
表2 五例结直肠癌大胆管转移患者诊治及复发情况
图1 结直肠癌大胆管转移生长方式病理学检查(HE ×200)注:a为扩张大胆管腔内见息肉样转移癌填充;b为胆管上皮被转移性结直肠癌细胞取代(箭头所示);c为肝实质转移癌破坏基底膜侵入小胆管(箭头所示)
图2 结直肠癌大胆管转移患者免疫组化检查(×200)注:a为残留胆管上皮CK7阳性,勾勒出扩张的胆管轮廓,胆管腔内癌细胞染色阴性,部分区域癌细胞沿着胆管基底膜取代胆管上皮(箭头所示);b为胆管腔内转移癌细胞浆CK20弥漫性阳性;c为胆管腔内转移癌细胞核CDX2阳性;CK为细胞角蛋白,CDX为尾部型同源框转录因子
[1]
Yao JF, Li XJ, Yan LK, et al. Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis[J]. J Biochem Mol Toxicol, 2019, 33(6):e22316.
[2]
Latorre Frague RA, Manuel Vazuze A, Rodrigues Figueira Y, et al. Intrabiliary metastases in colorectal cancer: a systematic review[J]. J Hepatobiliary Pancreat Sci, 2019, 26(7):270-280.
[3]
Estrella JS, Othman ML, Taggart MW, et al. Intrabiliary growth of liver metastases: clinicopathologic features, prevalence, and outcome[J]. Am J Surg Pathol, 2013, 37(10):1571-1579.
[4]
Reijonen P, Österlund P, Isoniemt H, et al. Histologically verified biliary invasion was associated with impaired liver recurrence-free survival in resected colorectal cancer liver metastases[J]. Scand J Surg, 2019, 108(3):201-209.
[5]
Chiu CT, Chiang JM, Yeh TS, et al. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?[J]. Dig Liver Dis, 2008, 40(9):749-754.
[6]
Zeng H, Xu LB, Wen JM, et al. Hepatocellular carcinoma with bile duct tumor thrombus: a clinicopathological analysis of factors predictive of recurrence and outcome after surgery[J]. Medicine, 2015, 94(1):e364.
[7]
Ghittoni G, Caturelli E, Viera FT. Intrabile duct metastasis from colonic adenocarcinoma without liver parenchyma involvement: contrast enhanced ultrasonography detection[J]. Abdom Imaging, 2010, 35(3):346-348.
[8]
Lokuhetty D, White VA, Watanabe R, et al. Digestive system tumours: WHO classification of tumours[M]. 5th ed. Geneva: World Health Organization, 2019:177-248.
[9]
Dong YM, Patel H, Patel C. Intrabiliary hepatic metastasis of colorectal carcinoma mimicking primary cholangiocarcinoma: a case report and review of the literature[J]. Case Rep Pathol, 2016:4704781.
[10]
Yamao T, Hayashi H, Higashi T, et al. Colon cancer metastasis mimicking intraductal papillary neoplasm of the extra-hepatic bile duct[J]. Int J Surg Case Rep, 2015(10):91-93.
[11]
Bayrak R, Haltas H, Yenidunya S. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-20+ phenotype is more specific than CDX2 antibody[J]. Diagn Pathol, 2012(7):9.
[12]
Sasaki S, Nomura Y, Fukutomi S, et al. Intrabiliary growth type of metastasis from colon cancer, 12 years after curative colectomy:a case report[J]. BMC Surg, 2019, 19(1):8.
[13]
中国医师协会外科医师分会,中华医学会外科分会胃肠外科学组,中华医学会外科分会结直肠外科学组, 等. 中国结直肠癌肝转移诊断和综合治疗指南(V2020)[J]. 中华胃肠外科杂志, 2021, 24(1):1-13.
[14]
Peungjesada S, Aloia TA, Kaur H, et al. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management[J]. AJR Am J Roentgenol, 2013, 201(4):W582-589.
[15]
Sugiura T, Nagino M, Oda K, et al. Hepatectomy for colorectal liver metastases with macroscopic intrabiliary tumor growth[J]. World J Surg, 2006, 30(10):1902-1908.
[16]
Wiggers JK, TeRiele WW, VanDongen TH, et al. Combined liver and extrahepatic bile duct resection for biliary invasion of colorectal metastasis: a case-cohort analysis and systematic review[J]. Hepatobiliary Surg Nutr, 2016, 5(4):350-357.
[17]
Zeng H, Shi GZ, Mai SY, et al. Imaging and clinical features of colorectal liver metastases with macroscopic intrabiliary growth[J]. Eur J Radiol, 2021(137):109616.
[18]
Akhtar M, Haider A, Rashid S, et al. Paget's "seed and soil" theory of cancer metastasis: an idea whose time has come[J]. Adv Anat Pathol, 2019, 26(1):69-74.
[19]
Fokas E, Engenhart-Cabillic R, Daniilidis K, et al. Metastasis: the seed and soil theory gains identity[J]. Cancer Metastasis Rev, 2007, 26(3/4):705-715.
[1] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[2] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[3] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[4] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[5] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[6] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[7] 阿冲罗布, 陈颖, 谢德坤. 腹腔镜外囊完整剥离术治疗肝包虫病效果及对患者肝功能、预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 666-669.
[8] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[9] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[10] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[11] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[12] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[13] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[14] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要